Phibro Animal Health Corp
Produces and markets animal health and mineral nutrition products
Stock Performance Snapshot
Analyst Rating
Analysts recommend holding Phibro Animal Health's stock with a target price of $15, indicating limited growth.
Financial Health
Phibro Animal Health Corp is showing strong revenue and cash flow, indicating good financial health.
Dividend
Phibro Animal Health's low dividend yield of 1.29% indicates limited returns from dividends. If you invested $1000 you would be paid $12.90 a year in dividends (based on the last 12 months).
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Baskets Featuring PAHC
Next-Gen Proteins
Looking to invest in the future of food? This carefully selected group of stocks represents companies solving our global protein challenges. From plant-based alternatives to agricultural innovation, these stocks have been thoughtfully chosen by our analysts for their potential in this growing market.
Published: June 17, 2025
Explore BasketPets Are Family
The emotional bond with our furry companions has created a powerful, recession-resistant market. These carefully selected companies provide essential veterinary care, nutrition, and wellness services that pet owners prioritize regardless of economic conditions.
Published: June 17, 2025
Explore BasketWhy You’ll Want to Watch This Stock
Livestock demand story
Global demand for meat and dairy can support sales of vaccines and feed additives, though results vary with commodity cycles and herd sizes.
Emerging market exposure
Sales growth may come from faster-expanding markets abroad, but exposure brings currency, regulatory and distribution risks.
Innovation and approvals
New product development and regulatory clearances can drive revenue, yet R&D and approval timing add uncertainty to earnings.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
Eli Lilly and Company
Eli Lilly & Co is a global pharmaceutical company that develops, manufactures and markets human prescription drugs.
Johnson & Johnson
Johnson & Johnson is a multinational conglomerate pharmaceutical, medical devices, and consumer packaged goods company.
AbbVie Inc.
Abbvie is a research-based biopharmaceutical company that develops and markets advanced therapies to address complex medical conditions.
